BridgeBio's Approach to Gene Therapy & Nearing the Clinic
Cleopatrabobb
24 min
Knowledge
Description
<p>BridgeBio's CEO of Gene Therapy, Dr. Eric David, explains the company's gene therapy programs for Canavan disease and congenital adrenal hyperplasia, their manufacturing plans, and the platform underpinning their novel approach to gene therapy.</p>
Uploader
alice.wave
Episodes
1
BridgeBio's Approach to Gene Therapy & Nearing the Clinic
Cleopatrabobb